You have no items in your shopping cart.
Search results for: 'IL-2'
- Featured
Featured
>95% as determined by SDS-PAGE
15 kDa
100 μg, 500 μg, 20 μg - ActiveActive
Unconjugated
90%
30.1 kDa
100 μg, 1 mg - ActiveActive
Unconjugated
95%
29.3 kDa
1 mg, 100 μg - RecombinantIL-21,Mouse [orb1494824]
> 95% as analyzed by SDS-PAGE.
15.1 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-21,Human [orb1494825]
> 95% by SDS-PAGE analysis.
15.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-1β,Rat [orb1494826]
> 95% by SDS-PAGE and HPLC analyses.
17.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-1β,Porcine [orb1494827]
> 95% as analyzed by SDS-PAGE.
17.7 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-1β,Mouse [orb1494828]
> 95% by SDS-PAGE and HPLC analyses.
17.5kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-1β,Human [orb1494829]
> 95% by SDS-PAGE and HPLC analyses.
17.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg - RecombinantIL-15,Human [orb1494832]
> 95% as analyzed by SDS-PAGE.
12.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
10 μg, 50 μg, 1 mg

